SUPN
$41.23+3.49%
Supernus Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.008% of ONEQUS Stock Market · 0.004% of VTIRussell 3000 · 0.003% of IWV
Supernus Pharmaceuticals Inc. total returns by year (including dividends)
As of market close, Oct 20, 2026
Supernus Pharmaceuticals Inc. total returns by year (2013–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $49.70 | $41.23 | 0.0% | -17.0% | |
| 2025 | $36.16 | $49.70 | 0.0% | +37.4% | |
| 2024 | $28.94 | $36.16 | 0.0% | +24.9% | |
| 2023 | $35.67 | $28.94 | 0.0% | -18.9% | |
| 2022 | $29.16 | $35.67 | 0.0% | +22.3% | |
| 2021 | $25.16 | $29.16 | 0.0% | +15.9% | |
| 2020 | $23.72 | $25.16 | 0.0% | +6.1% | |
| 2019 | $33.22 | $23.72 | 0.0% | -28.6% | |
| 2018 | $39.85 | $33.22 | 0.0% | -16.6% | |
| 2017 | $25.25 | $39.85 | 0.0% | +57.8% | |
| 2016 | $13.44 | $25.25 | 0.0% | +87.9% | |
| 2015 | $8.30 | $13.44 | 0.0% | +61.9% | |
| 2014 | $7.54 | $8.30 | 0.0% | +10.1% | |
| 2013 | $7.17 | $7.54 | 0.0% | +5.2% |
- Annualized
- +15.0%
- 2013–2026
- Average year
- +20.4%
- 13 full years
- Best year
- +87.9%
- 2016
- Worst year
- -28.6%
- 2019
- Positive years
- 10/13
- 77% up
Annualized (CAGR)
+15.0%
2013–2026
Average year
+20.4%
13 full years
Best year
+87.9%
2016
Worst year
-28.6%
2019
Positive years
10/13
77% up
Total return by period#
Annual
-50%0%50%
2013+5.2%'13
2014+10%'14
2015+62%'15
2016+88%'16
2017+58%'17
2018-17%'18
2019-29%'19
2020+6.1%'20
2021+16%'21
2022+22%'22
2023-19%'23
2024+25%'24
2025+37%'25
2026-17%'26
Methodology#
Total returns, dividends reinvested, measured on SUPN. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Supernus Pharmaceuticals Inc.'s average annual return?
- Since 2013, Supernus Pharmaceuticals Inc. (SUPN) has returned about 15.0% a year (the compound annual growth rate) and an average calendar-year return of 20.4%.
- What were Supernus Pharmaceuticals Inc.'s best and worst years?
- Over 2013–2026, the best year was 2016 (+87.9%) and the worst was 2019 (-28.6%).
- How often is Supernus Pharmaceuticals Inc. up in a year?
- 10 of the 13 full years since 2013 were positive — about 77% of the time.
More on Supernus Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100